Nikko Asset Management Americas’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45.7M Buy
666,581
+27,781
+4% +$1.58M 0.59% 45
2026
Q1
$41M Buy
638,800
+257,075
+67% +$23.4M 0.58% 45
2025
Q4
$49.6M Buy
381,725
+89,470
+31% +$12.3M 0.57% 50
2025
Q3
$31.4M Buy
+292,255
New +$31.8M 0.3% 73

Other funds holding WGS

Nikko Asset Management Americas's WGS Position: Q2 2026 in Review

Nikko Asset Management Americas increased its GeneDx Holdings (WGS) stake by 4.3% in Q2 2026, buying an estimated $1.58M and bringing the position to 666,581 shares worth $45.7M. The position accounts for 0.59% of the portfolio, ranked #45.

Nikko Asset Management Americas first reported a position in WGS in Q3 2025 and has held it in 4 quarters since. The position peaked at $49.6M in Q4 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Nikko Asset Management Americas held 666,581 shares of GeneDx Holdings worth $45.7M as of Q2 2026.
  • Nikko Asset Management Americas bought 27,781 GeneDx Holdings shares in Q2 2026, an estimated $1.58M.
  • GeneDx Holdings made up 0.59% of Nikko Asset Management Americas's portfolio in Q2 2026, its #45 holding.
  • Nikko Asset Management Americas first reported a position in GeneDx Holdings in Q3 2025 and has held it in 4 quarters since.
  • Nikko Asset Management Americas's GeneDx Holdings position peaked at $49.6M in Q4 2025.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Nikko Asset Management Americas's 13F filing for Q2 2026, filed 13 Aug 2026.